| http://www.w3.org/ns/prov#value | - European guidelines on the use of PDT for AK, Bowen's disease, basal-cell carcinoma or other emerging indications have recently been published.[40] At a practical level, office dermatologists rarely own red/blue lamps, which is one of the limits of this treatment.EffectivenessA complete clearance rate of treated lesions, ranging from 59% to 91% at 3 months, after two treatment sessions has been ob
|
